Cardiologia
#ACC21 – Estudo randomizado: entre pacientes com hipertensão resistente, a denervação renal por ultrassom resultou em melhora modesta na pressão arterial sistólica (- 4,2 mmHg) vs. procedimento simulado.
24 Mai, 2021 | 10:54hUltrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial – The Lancet (link para o resumo – $ para o texto completo)
Comentário: Renal Denervation for Resistant Hypertension Is Not Back on Track – “A systolic blood pressure (SBP) reduction of 4.5 mm Hg is not good enough—for an invasive procedure”. – Medscape (necessário cadastro gratuito)
Relatório final do estudo SPRINT: a meta de pressão arterial sistólica abaixo de 120 mmHg em pacientes com risco cardiovascular aumentado está associada a melhora nesse risco e nos desfechos de mortalidade, mas aumenta o risco de eventos adversos graves.
20 Mai, 2021 | 10:53hPesquisa global aponta que 44% dos cardiologistas relatam um ambiente de trabalho hostil. Foram encontradas taxas mais altas entre mulheres (68%) em comparação aos homens (37%).
20 Mai, 2021 | 10:52hGlobal Prevalence and Impact of Hostility, Discrimination, and Harassment in the Cardiology Workplace – Journal of the American College of Cardiology (link para o resumo – $ para o texto completo)
Editorial: Hostile Work Environment: A Case of the Emperor’s New Clothes
Comentário: Hostility Is Common in Cardiology: Can a New ACC/AHA Statement Help? – TCTMD
Comentário no Twitter
Global Prevalence and Impact of Hostility, Discrimination, and Harassment in the Cardiology Workplace – PubMed. A global problem for cardiology….What would you do… if it was career damaging to say nothing…and career damaging to speak up? https://t.co/uutfsMXOsx
— Sonya Burgess (@drsonyaburgess) May 15, 2021
Revisão da ESC: Atualização no tratamento da hipopotassemia em pacientes com doença cardiovascular.
20 Mai, 2021 | 10:46h
Comentário no Twitter
Learn about the management of hypokalemia: a comprehensive review from the ESC WG on cardiovascular pharmacotherapy https://t.co/MkwOZyvUJA@AgewallStefan @GianluSava #EHJPharmacotherapy #cardiotwitter pic.twitter.com/tUFVmycwHa
— European Society of Cardiology Journals (@ESC_Journals) May 15, 2021
#ACC21 – Estudo randomizado: Clopidogrel é melhor que aspirina para monoterapia de manutenção crônica após intervenção coronariana percutânea.
18 Mai, 2021 | 10:50hAspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial – The Lancet (necessário cadastro gratuito)
Comentários: Harmonizing Optimal Strategy for Treatment of coronary artery diseases-EXtended Antiplatelet Monotherapy – HOST-EXAM – American College of Cardiology E Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM – TCTMD
Comentário no Twitter
The sensational news of the day comes from South Korea. In a timely comparison of single antiplatelet monotherapies, clopidogrel beats aspirin during the chronic maintenance period after PCI, with curves diverging at 9 months. #ACC21https://t.co/Pp49LxcNWf pic.twitter.com/J9Un4QHzgL
— Davide Capodanno (@DFCapodanno) May 16, 2021
#ACC21 – Comissão do The Lancet sobre doença cardiovascular na mulher destaca 10 recomendações ambiciosas para melhorar a saúde de milhões de mulheres.
18 Mai, 2021 | 10:48hPágina: The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 – The Lancet (necessário cadastro gratuito)
Infográfico: Women and cardiovascular disease
Vídeo: The Lancet women and cardiovascular disease Commission
Comunicado de imprensa: Experts call for urgent action to reduce global burden of cardiovascular disease in women by 2030 – The Lancet
Comentário no Twitter (fio – clique para saber mais)
Cardiovascular disease is responsible for 35% of deaths in women yearly—yet remains:
❣️Understudied
❣️Under-recognised
❣️Underdiagnosed
❣️UndertreatedNEW @TheLancet Commission outlines 10 recommendations to improve health outcomes for millions of women: https://t.co/DDB97FFunC pic.twitter.com/WjV3aqqLV9
— The Lancet (@TheLancet) May 17, 2021
Consenso de especialistas sobre o rastreamento de lesão miocárdica perioperatória em cirurgia não cardíaca.
18 Mai, 2021 | 10:35hComentário convidado: Expert consensus on peri-operative myocardial injury screening in noncardiac surgery
#ACC21 – [Ainda não publicado] Estudo randomizado – DARE-19: Dapaglifozina é segura, mas não melhora significativamente o desfecho entre pacientes de alto risco hospitalizados com COVID-19.
17 Mai, 2021 | 09:43hVer também: Dapagliflozin in Respiratory Failure in Patients With COVID-19 – DARE-19 – American College of Cardiology
Comentários no Twitter
DARE-19 trial #ACC21 @ACCinTouch
Dapa did not reduce clinical endpoints in #COVID19, but excellent safety profile
🎯 Do not discontinue SGLT2i in 🏥 for #COVID19
Full slideset available in 👇https://t.co/RPi5mpPbbN pic.twitter.com/B9VQdSSAFu
— Enrique Santas (@SantasEnrique) May 16, 2021
DARE-19 findings presented at #ACC21 show #dapagliflozin didn’t significantly ⬇️ risk of organ failure or death or improve recovery in patients hospitalized w/ #COVID19. However, data suggest the SGLT2 inhibitor was well tolerated in acutely ill patients. https://t.co/YjYxbuc952 pic.twitter.com/J4PqwvGpLJ
— American College of Cardiology (@ACCinTouch) May 16, 2021
Perspectiva: Não existe “coração de Covid”.
17 Mai, 2021 | 09:41hSetting the record straight: There is no ‘Covid heart’ – STAT
Comentário no Twitter
Why the issue of Covid-19 induced cardiac problems was massively overblown and why screening low-risk patients with MRI and other fancy tests is neither necessary nor wise. https://t.co/HkJFOJ6oeM
— Raffaele Rasoini (@RasoiniR) May 14, 2021
#ACC21 – Estudo randomizado para mudança de prática: Em pacientes com fibrilação atrial (75% mantidos em anticoagulação), a oclusão do apêndice atrial esquerdo durante a cirurgia cardíaca reduz a incidência de AVC e embolismo sistêmico (4,8 vs. 7%) nos anos seguintes.
17 Mai, 2021 | 09:31hLeft Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentários: Simple surgery prevents strokes in heart patients – McMaster University E Occluding the LAA During Surgery Lowers Stroke Risk: LAAOS III – TCTMD
Vídeo: The Left Atrial Appendage Occlusion Study (LAAOS) III
Comentário no Twitter
A visual abstract of the #ACC21 Left Atrial Appendage Occlusion Study III is now available, evaluating surgical #LAAO compared with no occlusion among patients with #AFib undergoing open heart surgery for another indication. https://t.co/3iIhAEuGwk pic.twitter.com/e9Wq6Bp3Zz
— American College of Cardiology (@ACCinTouch) May 15, 2021